TABLE 2.
Susceptibilities of constructed mutants to various antibiotics
Strain | Relevant genotypea | MIC (μg/ml) ofb:
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPFX | CPFX | NFLX | LVFX | CZOP | CPR | CAZ | CPZ | CBPC | AZT | TC | CP | ||
PAO1 | Prototroph | 0.39 | 0.10 | 0.39 | 0.39 | 0.39 | 1.56 | 1.56 | 6.25 | 12.5 | 1.56 | 6.25 | 12.5 |
OCR1 | nalB | 1.56 | 0.78 | 3.13 | 3.13 | 1.56 | 6.25 | 6.25 | 25 | 100 | 12.5 | 25 | 100 |
KG2212 | PAO1 mexR::res-Ω | 1.56 | 0.39 | 1.56 | 1.56 | 0.78 | 3.13 | 3.13 | 12.5 | 50 | 6.25 | 12.5 | 50 |
KG2239 | PAO1ΔRABM | 0.05 | 0.012 | 0.05 | 0.05 | 0.10 | 0.39 | 0.20 | 0.39 | 0.39 | 0.10 | 0.20 | 0.78 |
KG3052 | Type-A nfxB | 6.25 | 1.56 | 6.25 | 3.13 | 3.13 | 6.25 | 0.78 | 3.13 | 6.25 | 0.78 | 12.5 | 25 |
KG2217 | KG3052 mexR::res-Ω | 6.25 | 1.56 | 6.25 | 3.13 | 3.13 | 6.25 | 3.13 | 12.5 | 50 | 6.25 | 25 | 50 |
KG2240 | KG3052ΔRABM | 6.25 | 1.56 | 6.25 | 3.13 | 3.13 | 6.25 | 0.39 | 0.78 | 0.39 | 0.10 | 3.13 | 12.5 |
KG3056 | Type-B nfxB | 12.5 | 3.13 | 12.5 | 6.25 | 6.25 | 12.5 | 0.78 | 3.13 | 1.56 | 0.39 | 25 | 50 |
KG2236 | KG3056 mexR::res-Ω | 12.5 | 3.13 | 12.5 | 6.25 | 6.25 | 12.5 | 3.13 | 25 | 50 | 6.25 | 25 | 50 |
KG2259 | KG3056ΔRABM | 12.5 | 3.13 | 12.5 | 6.25 | 6.25 | 12.5 | 0.78 | 1.56 | 0.39 | 0.10 | 25 | 50 |
ΔRABM, deletion of mexRAB-oprM operon.
Abbreviations: SPFX, sparfloxacin; CPFX, ciprofloxacin; NFLX, norfloxacin; LVFX, levofloxacin; CZOP, cefozopran; CPR, cefpirome; CAZ, ceftazidime; CPZ, cefoperazone; CBPC, carbenicillin; AZT, aztreonam; TC, tetracycline; and CP, chloramphenicol.